AstraZeneca expanding pain control centre in Montreal

Guest Contributor
February 26, 2007

AstraZeneca Canada Inc is investing $10 million in an expansion of its pain control research centre in Montreal. The $300-million centre opened in 1997 in the Saint-Laurent Technoparc by then Astra Pharma Inc and was the company's first major R&D facility outside of its home base in Sweden (R$, May 28/97). It employs 125 scientists and is one three basic pharmaceutical research centres in Canada. Since its inception it has discovered six promising compounds. The firm says the 1,000 sq-m expansion and new equipment will facilitate the transfer of chemists from a nearby site and provide room for future growth....


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.